Biomarkers and Microarrays

A biomarker, or regular marker, is a quantifiable pointer of some organic state or condition. A biomarker is a test that can be used to help break down a condition or to help screen a condition or response to treatment. They are used as a piece of various scopes of prescription both in standard restorative practice and besides in research, especially in clinical preliminaries. In medication, a biomarker can be a detectable substance that is brought into an actual existence structure as an approach to examine organ work or various pieces of prosperity. For example, rubidium chloride is used as a radioactive isotope to evaluate perfusion of heart muscle.

Biomarkers continue winding up continuously noteworthy in research and social protection applications, as affirm by the overall market for things required in their ID, endorsement, and use foreseen to accomplish USD 53.34 Billion by 2021 from USD 27.95 Billion of every 2016, creating at a CAGR of 13.8% in the midst of the guess time period (2016–2021).


    Related Conference of Biomarkers and Microarrays

    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    June 28-30 2020

    Stroke Summit 2020

    July 15-16, 2020

    12th World Congress and Expo on Stem Cell Research

    Prague, Czech Republic
    September 23-24, 2020

    24th European Biotechnology Congress

    Berlin, Germany
    October 19-20, 2020

    7th Asia Pacific Geriatrics and Gerontology Congress

    Tokyo, Japan
    October 23-24, 2020

    2nd International Conference on Biomarkers and Cancer Targets

    Cape Town, South Africa
    November 23-24, 2020

    International Conference on Toxicogenomics

    Bali, Indonesia
    December 07- 08, 2020

    2nd World Congress on Cell and Structural Biology

    Sydney, Australia
    December 14-15, 2020

    New frontiers in Genetics Research & Advanced Techniques

    San Antonio, USA

    Biomarkers and Microarrays Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in